© 2021 MJH Life Sciences™ and Modern Retina. All rights reserved.
John Pollack, MD
Articles
Encapsulated cell technology delivery of ciliary neurotrophic factor: promising treatment for macular telangiectasia type 2
July 30, 2021
Article
With orphan drug and fast track status, Neurotech plans to seek FDA approval for its NT-501 Implant platform late next year.